Nimbus COVID update: CDC tracker shows the NB.1.8.1 ‘razor blade throat' variant is now dominant
By spring, the variant was present in the United States, and by May, it began to gain a foothold when compared to other circulating variants. But as of last week, Nimbus has jumped to be the dominant strain of COVID-19 in the U.S. Here's what you need to know.
What is Nimbus?
As Fast Company previously reported, Nimbus is the nickname given to the NB.1.8.1 lineage of COVID-19. Nimbus is a subvariant of Omicron. The World Health Organization (WHO) says that Nimbus was first detected in January 2025 and soon after began circulating around the globe.
The Nowcast tracker operated by the U.S. Centers for Disease Control and Prevention (CDC) shows that by the week ending March 15, NB.1.8.1 was already detected in America. At that point, it accounted for a minuscule amount of COVID-19 cases in the country. Yet by the week ending April 26, NB.1.8.1 accounted for about 2% of all cases.
In May, Nimbus began to assert its rise to dominance. By the week ending May 10, NB.1.8.1 had risen to 5% of cases in the United States. That share jumped to 10% by May 24. By the week ending June 7, NB.1.8.1 accounted for 24% of COVID-19 cases in America, and, most recently, for the week ending June 21, it accounted for 43% of all COVID-19 cases in America, making it the now dominant variant in the U.S.
Which U.S. states is Nimbus in?
Just because Nimbus is now the most dominant COVID-19 variant in America doesn't mean it is circulating in all states.
But it also could be.
The uncertainty of where Nimbus is circulating is because a lower number of sequences are being reported to the CDC than in the past.
This makes it harder for the CDC to determine where and to what extent COVID-19 variants are spreading in America. Because of this lack of sequencing reporting, the CDC cautions that its Nowcast data's 'precision in the most recent reporting period is low.'
Arizona
California
Colorado
Hawaii
Illinois
Maryland
Massachusetts
Michigan
Nebraska
New Jersey
New York
Ohio
Rhode Island
Texas
Utah
Vermont
Virginia
Washington
That is four more states than GISAID data showed NB.1.8.1 earlier in June. The four new states where the variant has been detected this time around are Michigan, Nebraska, Texas, and Utah.
What are the symptoms of NB.1.8.1 Nimbus?
The symptoms of Nimbus are much the same as other symptoms of COVID-19. However, there are reports of people saying they feel more harsh throat pain with Nimbus than with previous variants. This throat pain is nicknamed 'razor blade throat' because it feels like you are swallowing razor blades.
Symptoms can include:
Body aches
Congestion
Cough
Fatigue
Fever or chills
Headache
Loss of smell
Loss of taste
Runny nose
Shortness of breath
Sore throat
What can I do to protect myself from Nimbus?
The precautionary measures you can take to mitigate the risk of contracting Nimbus are the same as those you would take for any other COVID-19 variant. The CDC says these measures include:
Staying up to date with COVID-19 vaccines
Practicing good hygiene
Make sure there is fresh, circulating air flowing through any spaces you are in. One way to help circulate fresh air through a space is by opening windows at home or in the office
Precautionary steps are important as Nimbus, like previous COVID variants, can be deadly. According to WHO data from the seven-day period ending June 8, there were 228 reported COVID-19-related deaths globally. A majority of those deaths—128 of them—occurred in the United States.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Health Line
13 minutes ago
- Health Line
What's the Connection Between Statins and Dementia?
There are conflicting research findings as to whether the use of statins can protect from dementia or increase the risk of dementia. While some older research has pointed to the possibility of a correlation, more recent studies showed that this drug class may lower your risk for dementia, including Alzheimer's disease. Statins are a type of medication taken to lower cholesterol levels in the blood. They prevent an enzyme called hydroxymethylglutaryl-CoA reductase (HMG-CoA reductase), which is involved in the production of cholesterol in the liver. Benefits of statins Benefits include lowering LDL ('bad') cholesterol levels, reducing the risk of heart disease, and preventing plaque buildup in your arteries. These medications include atorvastatin (Lipitor) and rosuvastatin (Crestor), among others. In 2012, the Food and Drug Administration issued a warning that statin use could rarely cause memory loss or confusion. The FDA later updated the findings that this cognitive decline was not significant. A growing body of research suggests statins may have a protective effect against dementia. A review of 31 studies published in 2018 supports the idea that statins can help prevent the risk of dementia. The researchers found that taking statins for 1 year decreased dementia risk by about 20%, while an average daily 5-milligram (mg) dose was associated with an 11% decrease in dementia risk. The researchers noted that because high cholesterol is a risk factor for dementia, lowering it could have positive effects on the brain. According to a 2020 review, statins may help short- and long-term delay of dementia progression in people over 65 years old with the condition, although the researchers noted that their findings were insufficient to make a definitive statement. Studies in 2021 and 2023 also pointed in the direction of statins having a protective effect against dementia, though the results were not conclusive. Research discrepancies Researchers in a 2022 study pointed out that discrepancies among studies is possibly related to smaller sample sizes and biases in the research methods, as well as wide ranges in the ages of participants, and co-existing conditions. Additionally, these researchers pointed out that different types of statins have different cognitive effects. Most scientists and medical professionals agree that more research is needed on the cognitive effects of statins, and there are studies in progress. If you have high cholesterol, it's important to get advice from a medical professional. High cholesterol is a risk factor for diseases that can affect your independence and life span, such as: heart disease dementia stroke heart attack While some people can experience improvement with lifestyle modifications, many who have high cholesterol need to take cholesterol-lowering medication. You and your doctor can discuss a plan that's individualized for you.
CNET
26 minutes ago
- CNET
Aurora Borealis May Hit These 16 States Over the Next Two Days
Alongside fireworks and drone shows, people in select parts of the US will have another excuse to look up at the sky this week. The sun has graced Earth with another round of solar material, which will interact with our atmosphere and make sections of the sky glow. Of course, we're talking about the aurora borealis, and it'll be visible in 16 states on Tuesday and Wednesday night. Of the two days, Tuesday night into Wednesday morning will be your best shot. The Space Weather Prediction Center is forecasting a Kp 5 magnetic storm that's scheduled to hit over six hours starting late Monday evening. The K-Index measures the horizontal impact of geomagnetic storms, and a Kp 5 rating results in what NOAA calls a "moderate" aurora. Things will calm down a bit Wednesday night going into Thursday morning, with the aurora pulling back a bit and being less visible unless you're on the northern border with Canada. NOAA is forecasting a Kp 4 magnetic storm that night. NOAA predicts the northern lights reaching into the US on Tuesday and Wednesday. NOAA Which states could see the aurora borealis? Per the Space Weather Prediction Center, Tuesday night's aurora will be visible in Washington state, Idaho, Montana, Wyoming, North and South Dakota, Minnesota, Iowa, Wisconsin, Michigan, and the northernmost sections of New York, Vermont, New Hampshire, and most of Maine. Alaska and Canada will have the best views by a wide margin, with the entire state of Alaska getting coverage. Technically, there will also be a slice of Oregon, putting the full number at 16, but unless you live on the northeastern tip, you likely won't see anything. Much like Earth's weather, space weather prediction can be hit or miss. So, if you're in any of the above states, it's worth taking a look if you're up that late. It may be slightly stronger or weaker than forecasted, which will affect how far south the northern lights reach. It won't be as strong as the epic show we saw in May 2024. Tips on viewing the northern lights The standard space viewing tips all apply here. You'll get a better view if you get away from the city and suburbs to avoid light pollution. Weather will play a role as well, since clouds will obfuscate the view. If you attempt to photograph the aurora, we recommend using long exposure times to give your camera more time to soak in the light. Other than that, you'll want to look toward the northern horizon to give yourself the best chance at a good view since that's where the northern lights originate.
Yahoo
26 minutes ago
- Yahoo
Man's body crawling with parasitic worms after infected kidney transplant at US hospital
When you buy through links on our articles, Future and its syndication partners may earn a commission. Two men were left riddled with parasitic worms after they received infected kidney transplants at two U.S. hospitals, a new case report reveals. The two kidneys had come from the same organ donor, who had resided in the Caribbean before death, according to the report, published June 18 in the New England Journal of Medicine. The first of the two kidney recipients, a 61-year-old man, had undergone transplant surgery at Massachusetts General Hospital (MassGen). Ten weeks after receiving the transplant, he was transferred back to MassGen after an initial admission to a different hospital. He had developed nausea, vomiting, excessive thirst, abdominal discomfort, back pain and a fever. At the first hospital, doctors found fluid building up in his lungs, and the man began breathing quickly, feeling as though he couldn't get enough air, and his oxygen levels dropped. As he entered respiratory failure and shock — meaning he had dangerously low blood pressure — he was transferred to the intensive care unit of MassGen, where doctors documented a purple rash, like a constellation of bruises, spreading across the skin of his stomach. The doctors began an extensive investigation into the patient's medical history and ran a battery of tests to pinpoint the cause of his symptoms. Related: 32 scary parasitic diseases The patient was on immunosuppressive medications to prevent his body from rejecting his new kidney, making him more susceptible to infections. The medical team, including infectious disease and organ transplant expert Dr. Camille Kotton, had the challenge of whittling down a lengthy list of possible infections to find the most likely cause. They could rule out bacterial infections, because the man had been given antibiotics and wasn't improving. He was also taking an antiviral and had tested negative for SARS-CoV-2, the virus behind COVID-19. That left some kind of parasite as a likely culprit. This was backed up by the fact that levels of eosinophils, a type of white blood cell that fights parasitic infections, had also spiked in the man's blood. These cells can also spike due to drug reactions or transplant rejection, but those causes were unlikely given the man's symptoms, Kotton noted. Kotton had heard of cases in which transplanted organs infected their recipients with a small roundworm called Strongyloides stercoralis. She contacted New England Donor Services, a regional organ-procurement organization, about the potential contamination. Although the kidney donor was deceased, they were able to test a vial of the donor's blood, which had antibodies for Strongyloides, meaning the donor's immune system had at some point encountered the worm. Tests of the patient's blood samples showed that he did not have antibodies to Strongyloides before the transplant, but he did afterward. When the medical team sampled various sites across the man's body, they found that the worms had spread far and wide, invading his abdomen, lungs and skin. Infections from transplants are rare — in over 10 years of transplants in the U.S., donor-derived infections affected only 14 out of every 10,000 organ transplants, a review found. U.S. doctors cannot use organs from people with certain active infections, such as tuberculosis, and donated organs are tested for infectious diseases, but these tests don't always catch everything. The review noted 13 proven or probable Strongyloides infections over a decade, accounting for 42% of all parasitic infections transmitted by organ transplants. Prior to this review, fewer than 1 in 4 organ transplant organizations regularly screened for Strongyloides, but in 2023, the Organ Procurement and Transplantation Network called for universal testing for this parasite. The MassGen medical team treated the man with ivermectin, a powerful antiparasitic drug. They received special permission to administer the drug directly underneath his skin to combat the full body infection, which ultimately cured him. RELATED STORIES —A man who couldn't pee had been infected by one of the largest known human parasites —Parasite lurking in woman's brain caused mysterious 'burning' leg sensation —Parasite that lived in woman's eye for 2 years likely came from crocodile meat Meanwhile, other medical centers that had transplanted organs from the same deceased donor were notified. This flagged a 66-year-old man who was being treated at Albany Medical Center for fatigue, low white blood cells and worsening kidney function following a transplant operation. Sharing notes with the MassGen team, the doctors were able to successfully treat this second patient, who had received the donor's other kidney. "Organ transplants save lives," a spokesperson for Albany Medical Center told Live Science in an email. "In rare cases like this, the communication and coordination between our hospitals and the involvement of infectious disease physicians at both hospitals was critically important, as was the alert our regional organ procurement organization provided us." Live Science have contacted MassGen for comment.
